TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
ANAB

AnaptysBio Inc

Healthcare · Biotechnology

55.10$ +1.4% vs. previous close Closing price · As of: Sep 17, 2026

Investor relations

Report Dates

Investor relations overview for AnaptysBio Inc (ANAB): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 08/05/2026.

Next report 08/05/2026
Last report 09/23/2026
Earnings surprise by quarter (%)
Q2 23 · 13.8 % 23 Q3 23 · 25.4 % 23 Q4 23 · 0.6 % 23 Q1 24 · -2.5 % 24 Q2 24 · -83.9 % 24 Q3 24 · 29.2 % 24 Q4 24 · 57.8 % 24 Q1 25 · 12.3 % 25 Q2 25 · 15.2 % 25 Q3 25 · 141.6 % 25 Q4 25 · 69.9 % 25 Q1 26 · -72.3 % 26

EPS estimate beaten

Full history 22 of 40 quarters (55%)
Last 16 quarters 10 of 16 quarters (63%)

Earnings Call Transcripts

Search all transcripts →

No transcripts yet — they will show up here automatically after the next earnings call.

News on This Stock

  • 08/11/2026 ANAPTYSBIO, INC (ANAB): Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits · sec.gov Open ↗
  • 07/30/2026 ANAPTYSBIO, INC (ANAB): Regulation FD Disclosure · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?